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Abstract
Background: Developed countries are facing a huge rise in the prevalence of obesity and its associated chronic
medical problems. In the UK Primary Care Trusts are charged with addressing this in the populations they serve,
but evidence about the most effective ways of delivering services is not available. The aim of this study is to
determine the effectiveness of a range of weight loss programmes for obese patients in primary care and to
determine the characteristics of patients who respond to an invitation to a free weight management programme.
Methods/Design: Lighten Up is a randomised controlled trial comparing a range of 12-week commercial and NHS
weight reduction programmes with a comparator group who are provided with 12 vouchers enabling free
entrance to a local leisure centre. The weight reduction programmes are: (i) Weight Watchers, (ii) Slimming World,
(iii) Rosemary Conley, (iv) a group-based dietetics-led programme (Size Down), (v) general practice one-to-one
counselling, (vi) pharmacy-led one-to-one counselling, (vii) choice of any of the 6 programmes. People with obesity
or overweight with a co-morbid disorder are invited to take part by a letter from their general practitioner. The
sample size is 740 participants.
The primary outcome is weight loss at programme-end (3 months). Secondary outcomes are weight-loss at one
year, self-reported physical activity at 3 and 12 months follow-up and percentage weight-loss at 3 months and
one year.
Discussion: This trial will provide evidence about the effectiveness of a range of different weight management
programmes in a primary care population.
Trial registration: Current Controlled Trials ISRCTN25072883
Background
In the UK the rates of obesity have more than doubled
in the last 25 years, and being overweight has become
the norm for adults [1]. In 2003/2004, the mean body
mass index (BMI) of men and women in the UK general
population was 27 kg/m
2, outside the healthy range of
18.5-25 kg/m
2 [2]. Health Survey for England 2008 data
showed that nearly a quarter of men (24%) and women
(25%) were obese [3], as defined by the World Health
Organisation (WHO) criteria of a BMI ≥ 30 [4]. In addi-
tion, levels of physical activity were very low with only
6% of men and 4% of women meeting the government’s
current recommendations for physical activity [3].
A number of chronic medical conditions are associated
with overweight and obesity, including type 2 diabetes,
hypertension, coronary heart disease and stroke, meta-
bolic syndrome, osteoarthritis and various cancers [2].
Health benefits have been reported with modest
weight loss of 5-10% from lifestyle interventions, with a
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any medium, provided the original work is properly cited.reduction in progression to diabetes of up to 58% over 4
years [5,6]. It is essential that we identify the best ways
to achieve and sustain such weight loss in the general
population. Douketis and colleagues [7] undertook a sys-
tematic review of controlled trials of weight loss inter-
ventions that had a follow-up of at least 2 years. In the
trials that reported the outcomes of dietary and lifestyle
therapy, a mean (sd) weight loss of 3.5 (+/- 2.4) kg was
reported after 2-3 years follow-up. However, 9 of the 16
trials reported loss to follow-up rates ranging from 31-
66% and 14 trials only reported the outcomes of study
completers, thus the effect of weight loss interventions
were probably over-estimated. Systematic reviews have
reported that combined diet and exercise interventions
result in a greater weight loss than dietary interventions
alone, both in the short and longer term [8,9]. Curioni
and colleagues reported the outcomes at 1 year or more
from 33 randomised controlled trials (RCT) of diet,
exercise, or diet and exercise [9]. Mean weight loss in
diet-only trials was 4.5 +/- 11.3 kg, compared to 6.7 +/-
8.3 kg in the trials of combined diet and exercise (p =
0.063). A systematic review of trials from the major
commercial and self-help weight loss programmes in the
USA concluded that much of the evidence was sub-opti-
mal, with many lacking evidence, poor quality design
and with high attrition rates [10].
Much of the research on the effectiveness of weight
loss interventions has been undertaken in the USA [8].
In the UK, the effectiveness of four commercial weight
loss programmes was evaluated in a publicly funded
randomised controlled trial [11]. This reported that all
four diets (Dr Atkins’ new diet revolution, Slim-Fast
plan, Weight Watchers pure points programme and
Rosemary Conley’s eat yourself slim diet and fitness
plan) resulted in clinically significant weight loss (aver-
age 5.9 kg) over the six months of follow-up. However,
the trial excluded people with chronic medical condi-
tions, such as coronary heart disease, had an upper age
limit of 65 years and obtained its participants via adver-
tising. This approach is likely to result in a sample that
is not typical of the population trying to lose weight and
targeted by primary care. By 12 months, follow-up was
only 54% and many had changed diet programme.
Weight loss at 12 months in those followed-up ranged
from 9.0-10.9 kg in the groups to which they were ori-
ginally allocated.
The UK Government White paper, ‘Choosing Health’,
identified inadequate provision of services for obesity
[12]. This may have stimulated development of new ser-
vices because a survey of 344 primary care organisations
in 2004 found that 51% had set up weight management
services in primary care [13]. A feasibility study of a
referral service to a commercial weight management
partner reported acceptable attrition rates and weight
loss in participants [14]. A primary care-based pro-
gramme for obesity management in the UK, the Coun-
terweight Programme, reported a clinically significant
weight loss of 5% or more in 30% of attendees at 12
months [15-17]. A small pilot trial of a 12 week nurse-
led programme in general practice reported a third of
the intervention group achieving at least a 5% reduction
i nb o d yw e i g h tc o m p a r e dt o2 0 %i nt h eu s u a lc a r ea r m
[18]. However the effectiveness of NHS weight loss ser-
vices have not been compared with commercial
providers.
This research protocol was developed in response to a
need for South Birmingham Primary Care Trust (PCT)
to develop services for the management of obesity. The
PCT had identified that there were insufficient weight
management services available in the National Health
Service (NHS) and wished to develop these. As part of
this, general practitioners (GPs) had been contracted to
record height and weight of their patients. One option
was for GP practices or NHS pharmacies to provide
weight management services, for which the PCT would
reimburse these practitioners. However, in the UK, there
are many well established commercial companies that
provide weight management services that are widely
recognised and commonly used by those seeking help to
lose weight. The PCT wished to contract with services
that would have a high reach, good acceptability, and
showed evidence of effectiveness and cost-effectiveness.
Thus the aim of this trial was to determine the effective-
ness of a range of NHS and commercial weight loss pro-
grammes in an unselected primary care population and
to determine the characteristics of people responding to
an unsolicited letter of invitation from their general
practitioner.
Methods/Design
The study design is a randomised controlled trial with
patients individually allocated to one of seven weight
loss programmes: (1) Weight Watchers, (2) Slimming
World, (3) Rosemary Conley (4) NHS group weight loss
programme (Size Down), (5) general practice one-to-one
support, (6) one-to-one pharmacist support and (7)
choice of intervention; with a minimal intervention con-
trol group provided with 12 vouchers enabling free
entrance to a local leisure centre.
Population
Eligible participants are registered with general practices
in South Birmingham Primary Care Trust, aged ≥ 18
years, with a raised BMI recorded within their primary
care notes within the previous 15 months. The BMI
threshold for invitation is that which makes them eligi-
ble for primary care obesity management services within
the NHS and varies according to ethnic group and the
Jolly et al. BMC Public Health 2010, 10:439
http://www.biomedcentral.com/1471-2458/10/439
Page 2 of 8presence or absence of co-morbidities. The threshold for
invitation for people with no obesity-related comorbidity
is a BMI of ≥ 30 Kg/m
2 in any ethnic group except South
Asian and BMI ≥25 Kg/m
2 in South Asians. For people
with obesity related comorbidity the threshold for invita-
tion is a BMI ≥ 28 Kg/m
2 for all ethnicities apart from
South Asians, for whom it is BMI ≥ 23 Kg/m
2.
Their GP has to confirm that they have no medical
contra-indications for any of the intervention pro-
grammes. Patients are excluded if they are unable to
understand English, are pregnant or are unwilling to be
randomised.
Recruitment commenced in January 2009. Each gen-
eral practice identifies eligible patients using a search of
the computerised clinical record and invites them by
standard letter to participate in the weight loss trial.
Practices are asked to exclude patients with serious co-
morbidities for whom weight loss programmes were
unfeasible or inappropriate, for example those with
terminal illness. The invitation letter contains informa-
tion about the trial and a toll-free telephone number for
a call centre managing the recruitment and randomisa-
tion. The nurses at the call centre provide more infor-
mation to patients about the trial, answer questions,
collect baseline information, take verbal consent and
randomise patients to the trial arms. The call centre
books participants into their first treatment session and
sends confirmation, along with verification of consent
and information on how to withdraw from the trial if
they change their minds. Participants allocated to the
general practice, pharmacy or minimal exercise interven-
tion (comparator) arms are sent details about how to
arrange their first session.
The randomisation sequence was prepared by an inde-
pendent statistician and to ensure blinding, each alloca-
tion was placed in an opaque, consecutively numbered
envelope. These are used in order by the call centre
staff, who record the number of the envelope and time
of randomisation to enable the study team to check
these are used in the correct order.
Following the first programme session, the call centre
telephones the participants to check whether they
attended and rebook appointments if necessary. If parti-
cipants have not attended and have no wish to do so,
nurses record the reasons for this.
Interventions
The content and delivery of the interventions are
described in the Table 1. In addition the interventions
have been classified according to Abraham and
Michie’s taxonomy of behaviour change techniques
[19] by extracting the elements of the interventions
from written manuals and materials provided by the
programmes.
The participants allocated to the commercial operators
Weight Watchers [20], Slimming World [21] and
Rosemary Conley [22] have a choice of programme loca-
tions and times. Commercially, these programmes run
continuously, with no set number of sessions and no
fixed starting date. People who are not participating in
the trial pay fees to attend these programmes and these
people attend alongside those in the trial, for whom
treatment is free. Each programme is provided in accor-
dance with the respective organisations’ guidance and
the group leaders are trained by the organisations. The
vouchers provided to trial participants exempts them
from payments for the first 12 weeks of the programme.
Thereafter, if participants wish to continue attending
sessions they are required to pay the appropriate fees to
the service provider. The Size Down Programme is an
NHS group-based programme in which all members of
the group commence together and follow a prescribed
course of sessions. It takes place in various community
venues. Participants randomised to the general practice
or pharmacy arms attend one-to-one sessions in the
general practice or pharmacy. Appointments are made
at a time mutually convenient to the participant and the
nurse/pharmacist.
In the choice arm, participants are able to choose
from any of the intervention programmes described
above.
Participants allocated to the comparator group are
sent vouchers for 12 free sessions to attend a local
authority run leisure centre (typically including an exer-
cise room, swimming pool, and other facilities such as
squash or badminton courts). Participants are not given
an appointment to attend and are given no dietary or
individual physical activity advice and support. It is
acknowledged that weight loss can occur with exercise-
only, but effects are modest [8,23].
Data collection
Baseline data
Data collected at baseline by the call centre, prior to
randomisation includes: demographic data, information
on previous use of weight loss programmes including
commercial services, current physical activity levels
(using the International Physical Activity Questionnaire-
short form (IPAQ-short)) [24] and use of weight loss
medication. Patients allocated to the choice arm are
asked about their reasons for choosing their programme.
When participants attend their first weight-loss ses-
sion in the six interventions, the leader/counsellor mea-
sures participants’ height and weight. Scales are
validated by the research team using standardised
weights, unless evidence of recent independent valida-
tion is provided. The commercial providers often use
self-reported height, so this will be re-measured at
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Page 3 of 8Table 1 Characteristics of weight management programmes
Weight Watchers Slimming World Rosemary Conley NHS Size Down General practice/
pharmacy
Professional
background of
therapist
Successful group
members selected
through interview
process. No formal
qualifications required
prior to training and
selection.
Successful group
members selected
through interview
process. No formal
qualifications required
prior to training and
selection.
Varied, may be
successful slimmers. No
formal qualifications
required prior to
training and selection.
Food advisors recruited
from local community.
No formal qualifications
required prior to training
and selection.
GP: practice nurse or
general practitioner
Pharmacy: pharmacist
Training of
therapist
4 visits to meetings to
observe and deliver
elements, admin
workshop;
3 day residential
workshop;
Further 4 meetings
delivering practical
elements, one admin
workshop.
4 day foundation
training course; 4
advanced training
courses.
OCR Exercise to music
training.
Certificate in applied
nutrition and weight
management.
Business management
and marketing.
Attendance at annual
training conferences
and convention.
NVQ level 3, 12 × 2.5
hour training sessions
from dieticians and
nutritionists. 18
assessments.
2 day adult weight
management course.
Assessment of
therapist’s
competence
Assessed by area
manager, who has
observed all training
sessions apart from 3-day
workshop.
Completion of training
course and 4 diploma
exams. Observations at
1
st and 6
th sessions
(minimum); twice yearly
development visits by
manager.
Theoretical papers and
practical assessment by
independent body.
Assessed taking class
once started.
Annual business
review.
Observed running
session prior to passing
the course.
Observed during the
training course by leader
e.g. Q&A, mock-
interviewing.
Fidelity
checking of
intervention
Regular observations by
area service manager.
Buddy system during first
year.
Weekly planning and
training phone call with
manager; regular
observations of groups.
Monitoring of retention
to group, weight loss
achieved.
Mystery shoppers used.
Random checks.
Monthly supervision
meetings.
None.
Programme
Characteristics
Weight Watchers Slimming World Rosemary Conley NHS Size Down General practice/
pharmacy
Group or
individual
Group. 1-2-1 for new
members and when
weighed. Group talk
from leader with
discussion.
Group. 1-2-1 when
weighed. Group used to
share progress and
lapses and to find and
share solutions.
Group. 1-2-1 when
weighed and to
establish calorie
allowance.
Also, additional support
available via email/
telephone 1-2-1.
Group. Group used to
share progress and
lapses and to find and
share solutions. All
group members start in
same week and progress
as a closed group.
Individual
Duration of
sessions,
frequency,
programme
length and
setting
1 hour sessions.
12 weekly sessions
provided as part of
Lighten Up.
Community based
venues.
1 1/2 hour sessions.
12 weekly sessions
provided as part of
Lighten Up.
Access to website,
magazines and 1-2-1
telephone support from
consultant or other
members.
Community based
venues.
1 1/2 hours
12 weekly sessions
provided as part of
Lighten Up.
Community based
venues.
2 hour duration;
groups weekly × 6
weeks; drop-in at 9 and
12 weeks.
Community based
venues. All group
members start in same
week and progress as a
closed group.
1
st session 30 minutes,
follow up sessions 15-20
minutes
12 weekly sessions
provided as part of
Lighten Up - although
may not have taken
place weekly in all cases.
In surgery or pharmacy.
Content of
sessions
Core programme
material delivered over
5-weeks: food points
system (based on age,
gender, height, weight &
activity), beating hunger,
taking more physical
activity, eating out and
keeping motivated. Other
sessions delivered to
whole group cover
recipes, health and
nutrition and keeping
active.
Encouraged to eat
mainly low energy
dense foods to achieve
satiety, plus some extras
rich in calcium and fibre,
with controlled amounts
of high energy dense
foods.
Weight loss and
improved diet, fitness
and improvement of
physical condition,
motivation and self
esteem, use of group
support.
Use of portion pots.
Motivational video.
Managing behaviour
around food and relapse
prevention; eatwell plate
[25]; nutrition
information; interactive
style used.
Planning strategies to
deal with lapses into
previous dietary
behaviours.
Sessions client led and
based around a problem
solving approach.
Weight and dieting
history; exploration of
goals & expectations of
patients; eatwell plate;
setting goals to reduce
calorie intake & increase
physical activity.
Planning strategies to
deal with challenging
situations. Use of food
diaries.
Maintaining weight loss
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Page 4 of 8follow-up by the blinded assessor. People in the com-
parator control group and people who are randomised
but who do not attend their allocated programme are
contacted and a researcher makes an appointment to
measure height and weight.
During the 12-week programmes the service providers
record weights on each visit. The comparator group are
weighed at baseline only.
Outcome assessment
The primary outcome is weight loss at three months fol-
low-up. The secondary outcomes are self-reported phy-
sical activity using the IPAQ-Short version, weight loss
at one year and percentage weight loss at 3 months and
one year.
At three months after programme start (programme
end) the service providers weigh participants. Partici-
pants who are no longer attending their allocated pro-
gramme are contacted and offered follow-up at home or
another convenient location. If participants decline to be
followed-up in person, they are asked to provide a self-
reported weight, which is recorded as self-report. In
addition, the IPAQ-short is administered by phone and
participants who have dropped out of their allocated
programme are sent an open-ended question asking for
their views about the weight loss programme to which
they were allocated.
The final outcome assessment takes place one year
after randomisation. In addition to assessment of their
Table 1 Characteristics of weight management programmes (Continued)
Weight-loss
goal
0.5 to 1 kg per week
(plan aims for 500 kcals
deficit/day)
Set by individual. Staged goals: either 1-
1.5 kgs per week with
goal of (1 stone) loss
or 0.5-1 kg per week
with 3.2 kg (7 lb) initial
goal.
Participants told they
can lose 2% of body
weight in 12 weeks
5-10% of starting body
weight, at a rate of 0.5-1
kg per week over 3-6
months, followed by
maintenance
Relative
emphasis on
diet and
exercise
Diet>exercise.
Physical activity
encouraged, objective to
gradually build up to
10,000 steps daily.
Diet>exercise.
Physical activity
encouraged, with
gradual build up to 30
mins moderately intense
activity 5 days a week.
Diet=exercise
45 mins (of 11/2 hour
sessions devoted to
optional exercise class.
Extra exercise sessions
may be offered for
additional fee.
Diet>activity, but time
spent on benefits of
physical activity, setting
goals and finding
activities to fit into life.
Diet=exercise
Aim to slowly increase
activity levels to achieve
30 minutes of moderate
activity, 5 days each
week;
Intervention
theoretical
background
Not stated Transactional analysis,
motivational
interviewing; awareness
of Ego States.
Not stated Process of change [26]
(Prochaska &
diClemente)
Stages of change;
motivational
interviewing
Predominant
behavioural
change
techniques
used
Stages of change, food
and activity diaries, goal
setting and evaluation of
progress.
Rewards for every 3.2 kg
(7 lbs) lost, 5% and 10%
of body weight.
Weekly weighing; group
support, group praise for
weight loss, new
decisions and continued
commitment even in
absence of weight loss.
Awards for 3.2 kg (7 lbs)
lost and loss of 10% of
body weight. Individual
support if needed using
self-monitoring of food
and emotions, for and
against evaluations,
visualisation techniques,
personal eating plans.
Role modelling, group
support. Visualisation
and reframing to
support behaviour
change.
Rewards for slimmers
who maintain weight
or lose, slimmer of the
week and certificates
for 3.2 and 6.35 kg
(7 lb and 1stone)
milestones.
Goal setting; stages of
change; self-monitoring
via food diary.
Goal setting; self-
monitoring via food
diaries, hunger scale,
waist measurements and
physical activity.
Resources to provide as
homework to then
discuss in next session
or act as personal
reflection. Encouraged to
make rewards to self for
success.
Behavioural
change
techniques
used (Michie
categories*)
1, 4, 11, 12, 13, 14, 7, 14,
19
1, 8, 10, 11, 13, 5, 7, 23,
14, 19, 25
1, 6, 8, 4, 12, 13, 14, 19 1, 6, 8, 4, 10, 11, 12, 5,
23, 18, 26
1, 4, 12, 13, 5, 23,25, 26
*EDUCATIONAL ACTIVITIES: 1. Provide general information on behaviour-health link; 2. Provide information on consequences; 3. Provide information about others’
approval; 6. Provide general encouragement; 8. Provide instruction; 9. Model/Demonstrate the behaviour.
SELF-MONITORING: 4. Prompt intention formation; 10. Prompt specific goal setting; 11. Prompt review of behavioural goals; 12. Prompt self-monitoring of
behaviour; 13. Provide feedback on performance.
INTENTION FORMATION AND PLANNING: 5. Prompt barrier Identification; 7. Set graded tasks; 23. Relapse prevention.
BEHAVIOURAL TECHNIQUES TO SUPPORT CHANGE: 14. Provide contingent rewards; 15. Teach to use prompts/cues; 16. Agree behavioural contract; 17. Prompt
practice; 18. Use of follow up prompts; 19. Provide opportunities for social comparison; 20. Plan social support/social change; 21. Prompt identification as role
model/position advocate; 22. Prompt Self talk.
SPECIFIC OTHER TECHNIQUES: 24. Stress management; 25. Motivational interviewing; 26. Time management.
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Short, their opinion of the service and whether they
have tried any other weight loss programmes or strate-
gies over the course of the year. Participants are invited
to attend their general practice for a brief appointment,
where the practice nurse or a health trainer who is
blind to the allocation arm, undertake follow up mea-
sures. Participants unable to attend their general prac-
tice will be offered home visits for measurements. If
height has not been measured previously, it is assessed
using a Leicester height measure. Participant flow
through the trial is shown in figure 1.
Sample size
A sample size calculation based on detecting a 2 kg
difference in weight loss at the 12 week follow-up
between any of the planned interventions and com-
parator group, with 90% power and 5% significance
level found that 70 participants randomised to each
group will be sufficient. This estimate is based on a
standard deviation of 3.2 kg [11,14] and allows for a
20% dropout rate. To enable a more realistic drop-out
rate and to get greater precision, 100 participants were
allocated to each arm. However, not many general
practices or pharmacies were prepared to offer treat-
ment themselves and training places were limited, so
that only 70 will be allocated to these arms. A total of
740 participants will be randomized.
Planned analysis
Both between and within group analyses for primary
and secondary outcomes at programme end and 12
months will be performed according to intention to
treat. Participants in whom weight at follow up is not
available will be assumed to have their baseline weight.
However, sensitivity analysis will also be undertaken,
assuming follow up weight to be the last recorded
weight.
As the outcomes are all measured on a continuous
scale (weight loss, percentage weight loss, self-reported
physical activity), differences between intervention group
and the comparison (minimal intervention) group will
be investigated using least squares linear regression.
Between group analyses will be expressed as both unad-
justed and adjusted differences (corrected for baseline
score and covariates of age, gender, ethnicity and educa-
tional level). A secondary analysis will compare the out-
comes of the commercial weight loss programmes
(Weight Watchers, Slimming World and Rosemary Con-
ley) with the primary care programmes (general practice
and pharmacy-based interventions). Data on choice of
programme, number of sessions attended and reasons
1
Practices run searches for patients with raised BMI 
GPs screen list for patients with serious comorbidity
Practice sends letter to overweight patients inviting them to free weight loss programme. Letter states that they will be required to provide PCT with 
data on their progress as the programmes are being evaluated. Patient information leaflet sent with the invitation letter.
Free phone number for the call centre provided
Interested patients telephone call centre
Call centre explains that they will be randomly allocated to a programme after they have provided some details about themselves
Patients give verbal consent.  Baseline data collected over phone.  Randomisation to one of 8 groups
Commercial
programme: 
Weight Watchers
n=100 
Size Down
Group-based NHS 
community weight loss 
programme 
n=100 
All programmes collect data on weight and physical activity at baseline (entry to programme)
All programmes collect data on weight and physical activity at 3 months (end of programme)  
Research team collect data from those who have dropped out of their programme
Blinded follow-up of all participants at 12 months
General practice
One-to-one 
programme 
n=70
Commercial programme: 
Rosemary Conley 
n=100
Commercial
programme: 
Slimming World 
n=100
Minimal intervention 
comparator 
n=100 
Choice
Participants can choose 
any of 6 intervention 
programmes 
n=100
Pharmacy
One-to-one 
programme 
n=70
Figure 1 Patient flow through trial.
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Page 6 of 8for drop-out will be presented using descriptive
statistics.
To determine whether the service reaches those most
in need, the age, gender, and deprivation score (derived
from the postcode of residence) of those who were ran-
domised will be compared to those who received the let-
ter but did not respond or declined to be randomised.
Responses to open-ended questions about experience
of the service and reasons for dropping out of their allo-
cated programme will be categorised and presented
descriptively.
Costs
An NHS perspective will be taken in the cost analysis.
The price to the PCT of each programme will be used.
The cost of the call center which co-ordinated the ser-
vice will be calculated as an average per person, based
on the numbers of staff employed over a 12 month per-
iod and clients who used the service over this time per-
iod. The mean cost per kg of weight lost will be
determined for each programme.
Ethical approval
Ethical approval was granted by South Birmingham
Research Ethics Committee (08/H1207/331).
Discussion
A quarter of the UK population and a similar high pro-
portion in other countries are obese. If primary care
clinicians were to manage this disorder, it would poten-
tially mean a large proportion of their time being
devoted to it. Commercial weight loss organizations
have a large network of treatment services that provide
a cheaper alternative to primary care services. However,
the comparative effectiveness and the cost-effectiveness
is unknown. This trial aims to provide these data.
One important aspect to this work is that it is a
weight loss trial recruiting in primary care among
those who have not specifically sought treatment.
Many published weight loss intervention trials treat
patients in specialist obesity clinics. These clinics pro-
vide treatment for only a minority of all people who
need it. In particular, in this study, we will be able to
examine uptake of obesity management services in
response to an invitation. We are not aware of any
other study that has examined uptake in a defined
population in this way.
Robust clinical trial results are not available for all the
commercial providers in this trial and for few primary
care led programmes, so this research will extend
knowledge about the efficacy of commercial and com-
munity weight loss programmes. In addition our partici-
pants were responders to an invitation from their
general practitioner, whereas many other trials have
recruited volunteers, who are likely to be more moti-
vated to lose weight. This trial will inform decisions
about which weight loss programmes might make useful
clinical contributions for patients with obesity and
which might have useful contributions to reducing the
public health toll of obesity.
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